Blog

Cancers of the oesophagogastric junction (OGJ) and proximal stomach are aggressive malignancies where accurate post-treatment assessment is critical for long-term outcomes. Conventional imaging may fail to differentiate residual disease from post-treatment changes.
⁶⁸Ga-FAPI PET-CT, a novel molecular imaging technique targeting cancer-associated fibroblasts, offers superior tumor visualization with low background uptake, making it highly effective in therapy response evaluation.

This case highlights the clinical value of ⁶⁸Ga-FAPI PET-CT in post-chemoradiation follow-up of OGJ carcinoma 

By Dr. Rashmi Angadi – Nuclear Medicine Consultant, NeuMoD Digital PET-CT & Molecular Theranostics

Cancer care has come a long way, and at the heart of this transformation lies Nuclear Medicine—a powerful branch of medicine that merges diagnosis with treatment. In Hubballi, patients no longer need to travel to metro cities for cutting-edge cancer care. At NeuMoD Digital PET-CT & Molecular Theranostics, we bring world-class imaging and personalized cancer therapies to your doorstep.